NEW YORK (GenomeWeb) – Epigenomics today announced a 66 percent jump in third quarter revenues due to an increase in product sales, the firm said.

For the three months ended Sept. 30, the German molecular diagnostics firm reported revenues of €471,000 ($502,482) compared to €284,000 in Q3 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.